Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134648) titled 'Prediction of sentinel lymph node metastasis and high nodal burden based on hematological parameters and clinical characteristics in clinically node-negative early invasive breast cancer' on Oct. 19.

Study Type: Observational study

Study Design: Factorial

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

Condition: cN0 early-stage invasive breast cancer

Intervention: SLN-positive group?SLN-negative group

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-28

Target Sample Size: SLN-positive group?SLN-negative group;High lymph node burden?Low lymph node bur...